EUVIMEDEUVIMED entdecken
Crossref

An integrated network pharmacology and molecular docking approach to reveal the role of Arctigenin against Cutibacterium acnes‐ induced skin inflammation by targeting the CYP19A1

Xiaoyan Lu iD, Yanzhong Han, Yongkang Zhang, Rui Li, Jiaoyan Xu, Jian Yang, Jingchun Yao, Zhihai Lv

Chemical Biology & Drug Design · 2024

DOI: 10.1111/cbdd.14598 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2024. Verfasst von Xiaoyan Lu und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Linyi, People's Republic of China. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Furans, Lignans, Acne Vulgaris. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, Taishan Industry Leading Talent Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acne caused by inflammation of hair follicles and sebaceous glands is a common chronic skin disease. Arctigenin (ATG) is an extract of Arctium lappa L., which has significant anti‐inflammatory effects. However, the effect and mechanism of ATG in cutaneous inflammation mediated by Cutibacterium acnes ( C . acnes ) has not been fully evaluated. The purpose of this study was to explore the effect and potential mechanism of ATG in the treatment of acne through network pharmacology and experimental confirmation. An acne model was established by injected live C. acnes into living mice and treated with ATG. Our data showed that ATG effectively improved acne induced by live C. acnes , which was confirmed by determining ear swelling rate, estradiol concentration and hematoxylin and eosin (H&E) staining. In addition, ATG inhibited the NLRP3 inflammasome signaling pathway in mice ear tissues and reduced the secretion of pro‐inflammatory cytokines IL‐1β to relieve inflammation. The results of network pharmacology and molecular docking confirmed that ATG can regulate 17β‐Estradiol (E2) levels through targeted to CYP19A1, and finally inhibited skin inflammation. Taken together, our results confirmed that ATG regulated E2 secretion by targeting CYP19A1, thereby inhibiting the NLRP3 inflammasome signaling pathway and improving inflammation levels in acne mice. This study provides a basis for the feasibility of ATG in treating acne in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Docking SimulationFuransLignansAcne VulgarisAromataseNetwork PharmacologyAnimalsMiceSignal TransductionSkinInflammationNLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesHumansAnti-Inflammatory AgentsPropionibacterium acnesInterleukin-1betaDisease Models, Animal

Stichwörter der Autor:innen

17β‐EstradiolArctigeninCYP19A1NLRP3 inflammasomeacne

Substanzen

arctigeninFuransLignansAromataseNLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesAnti-Inflammatory AgentsInterleukin-1beta

Autor:innen und Institutionen

  • State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Linyi, People's Republic of China.
  • National Engineering and Technology Research Center of Chirality Pharmaceutical, Linyi, People's Republic of China.
  • College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, People's Republic of China.
  • Longgang District Maternity and Child Healthcare Hospital of Shenzhen City, Shenzhen, People's Republic of China.

ORCID-Profile: Xiaoyan Lu

Förderung

  • Natural Science Foundation of Shandong Province
  • Taishan Industry Leading Talent Project

Zitieren

APA

Lu, X., Han, Y., Zhang, Y., Li, R., Xu, J., Yang, J., Yao, J., & Lv, Z. (2024). An integrated network pharmacology and molecular docking approach to reveal the role of Arctigenin against Cutibacterium acnes‐ induced skin inflammation by targeting the CYP19A1. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14598

Vancouver

Lu X, Han Y, Zhang Y, Li R, Xu J, Yang J, et al. An integrated network pharmacology and molecular docking approach to reveal the role of Arctigenin against Cutibacterium acnes‐ induced skin inflammation by targeting the CYP19A1. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.14598

BibTeX
@article{Lu2024,
  author = {Lu, Xiaoyan and Han, Yanzhong and Zhang, Yongkang and Li, Rui and Xu, Jiaoyan and Yang, Jian and Yao, Jingchun and Lv, Zhihai},
  title = {An integrated network pharmacology and molecular docking approach to reveal the role of Arctigenin against Cutibacterium acnes‐ induced skin inflammation by targeting the CYP19A1},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  doi = {10.1111/cbdd.14598}
}
Kostenlos starten →